Signs of Life in Tokyo?


Signs of Life in Tokyo?


Following the election of Emmanuel Macron in May this year and his success in the general election the following month, the market seems to have developed a crush on all things European. Expectations of recovering economic growth and a rejuvenation of the euro in a “two speed” Union has pulses racing. Twelve-month forward earnings expectations for the MSCI Europe ex UK Index have risen 17% since October 2016, with the index itself up over 20% in the same period. Meanwhile, on the other side of the world, Japan has been undergoing a major recovery of its own, largely without participation by foreign investors. Japanese earnings expectations rose 18% over the last 12 months and the MSCI Japan Index is up 25%.1 However, despite the nominal similarity, there are significant differences between the two trends.


With the MSCI World Index trading at 16.8x 12M forward P/E, and the U.S. at 18.2x, the valuations for Europe ex UK stocks at 15.5x and Japan at 14.7x look positively attractive3 for global investors.


The year-on-year improvement of earnings expectations in Europe was driven by Financials, Consumer Discretionary, Industrials and Materials, which contributed more than half of the growth, while 90% of the earnings improvement in Japan came from Industrials, Consumer Discretionary and Technology.2 The European earnings outlook, therefore, depends heavily on a cyclical recovery in commodity demand as well as hopes for rising interest rates. On the other hand, Japan has benefitted more broadly from a recovery in demand for its products as well as a significant improvement in margins – supported by helpful currency moves.

With the MSCI World Index trading at 16.8x 12M forward P/E, and the U.S. at 18.2x, the valuations for Europe ex UK stocks at 15.5x and Japan at 14.7x look positively attractive3 for global investors. One should note, however, that the delta between Europe and Japan widens further when the sector distribution is taken into account.4 With the exception of Consumer Staples and Health Care, which are much smaller sectors in Japan, the other sectors mostly trade at multiples below, and in the case of Industrials, well below, European valuations.

Following the recent re-election of Shinzo Abe, Japan has now become one of the few countries in the G7 with an elected government that relies on a majority traditional party. In the Eurozone, France is ruled by a president and party that have not been tested, while Germany struggles to create a new government and Italy faces elections in the new year. Meanwhile, the UK is struggling with Brexit and the U.S. is trying to find a modus operandi with its new president. That leaves Canada as the only other G7 member with a “traditional” political environment.

As a team, we have often been sceptical of Japan, mainly because the capital allocation decisions of Japanese management teams have frequently been hard to fathom. The return on capital of listed Japanese companies still stands at around half the level of the global market. Reasons for this vary but typically include expensive acquisitions, sometimes in areas where the acquirer has little expertise, large cross-shareholdings with little or no economic rationale, unnecessarily huge cash buffers, poor discipline on price, a high tolerance for inefficiencies and weak governance.


Quality in Japan, when found, is the most expensive in the developed world… some 50% more expensive than our quality portfolios...


As always, our approach as investors is bottom-up and fundamentally driven, but we do monitor Japanese government efforts to bring about change and we are beginning to see some improvement to returns across the market. For now, we have no Japanese companies in the portfolio. Frankly, we find quality is scarce in Japan, with only 12% of the market qualifying for the returns, margin and balance sheet profiles we look for. This is before any assessment of the quality of the franchise or management, which disqualifies the remaining names to very few indeed. Moreover, this scarcity comes at a price. Quality in Japan, when found, is the most expensive in the developed world, trading at a median FCF yield of 3.3%,5 some 50% more expensive than our quality portfolios which trade at just a 10% premium to the broader market for significantly higher quality. So for now, we wait in the wings for valuations to become more palatable, and for Japanese management to become more shareholder focused and returns-driven.

Managing Director
Head of International Equity Team
Executive Director

1. Source: FactSet, as of 31 October 2017.

2. Source: FactSet/MSCI , as of 31 October 2017; Bloomberg.

3. Source: FactSet, as of 31 October 2017.

4. Source: FactSet, as of 31 October 2017.

5. Source: FactSet, as of 31 October 2017.

This material is for use of Professional Clients only, except in the U.S. where the material may be redistributed or used with the general public.

The views and opinions are those of the author as of the date of publication and are subject to change at any time due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all portfolio managers at Morgan Stanley Investment Management (MSIM) or the views of the firm as a whole, and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific Morgan Stanley Investment Management product.

Certain information herein is based on data obtained from third party sources believed to be reliable. However, we have not verified this information, and we make no representations whatsoever as to its accuracy or completeness.

All information, which is not impartial, is provided for informational and educational purposes only and should not be deemed as a recommendation. The information herein has not been based on a consideration of any individual investor circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

The MSCI Europe ex UK Index captures large- and mid-cap representation across 14 developed market countries in Europe. With 336 constituents, the index covers approximately 85% of the free float-adjusted market capitalization across European developed markets excluding the UK.

The MSCI Japan Index is a free-floated adjusted market capitalization weighted index that is designed to track the equity market performance of Japanese securities listed on the Tokyo Stock Exchange, Osaka Stock Exchange, JASDAQ and Nagoya Stock Exchange. The MSCI Japan Index is constructed based on the MSCI Global Investable Market Indices Methodology, targeting a free-float market capitalization coverage of 85%.

The MSCI World Index is a free float adjusted market capitalization weighted index that is designed to measure the global equity market performance of developed markets. The term "free float" represents the portion of shares outstanding that are deemed to be available for purchase in the public equity markets by investors. The performance of the Index is listed in U.S. dollars and assumes reinvestment of net dividends. The index is unmanaged and does not include any expenses, fees or sales charges. It is not possible to invest directly in an index.


There is no assurance that a portfolio will achieve its investment objective. Portfolios are subject to market risk, which is the possibility that the market value of securities owned by the portfolio will decline. Accordingly, you can lose money investing in this strategy. Please be aware that this strategy may be subject to certain additional risks. Changes in the worldwide economy, consumer spending, competition, demographics and consumer preferences, government regulation and economic conditions may adversely affect global franchise companies and may negatively impact the strategy to a greater extent than if the strategy's assets were invested in a wider variety of companies. In general, equity securities values also fluctuate in response to activities specific to a company. Investments in foreign markets entail special risks such as currency, political, economic, and market risks. Stocks of small-capitalization companies carry special risks, such as limited product lines, markets and financial resources, and greater market volatility than securities of larger, more established companies. The risks of investing in emerging market countries are greater than risks associated with investments in foreign developed markets. Non-diversified portfolios often invest in a more limited number of issuers. As such, changes in the financial condition or market value of a single issuer may cause greater volatility.

This communication is not a product of Morgan Stanley's Research Department and should not be regarded as a research recommendation. The information contained herein has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This communication is only intended for and will be only distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the strategy's/product's relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.


This communication was issued and approved in the United Kingdom by Morgan Stanley Investment Management Limited, 25 Cabot Square, Canary Wharf, London E14 4QA, authorized and regulated by the Financial Conduct Authority, for distribution to Professional Clients only and must not be relied upon or acted upon by Retail Clients (each as defined in the UK Financial Conduct Authority's rules).

Financial intermediaries are required to satisfy themselves that the information in this document is suitable for any person to whom they provide this document in view of that person's circumstances and purpose. MSIM shall not be liable for, and accepts no liability for, the use or misuse of this document by any such financial intermediary. If such a person considers an investment she/he should always ensure that she/he has satisfied herself/himself that she/he has been properly advised by that financial intermediary about the suitability of an investment.


A separately managed account may not be suitable for all investors. Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing. A minimum asset level is required. For important information about the investment manager, please refer to Form ADV Part 2.

Please consider the investment objectives, risks, charges and expenses of the funds carefully before investing. The prospectuses contain this and other information about the funds. To obtain a prospectus please download one at or call 1-800-548-7786. Please read the prospectus carefully before investing.

Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley funds.


Hong Kong

This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to "professional investors" as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed nor approved by any regulatory authority including the Securities and Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong.


This document should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore ("SFA"), (ii) to a "relevant person" (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. In particular, for investment funds that are not authorized or recognized by the MAS, units in such funds are not allowed to be offered to the retail public; any written material issued to persons as aforementioned in connection with an offer is not a prospectus as defined in the SFA and, accordingly, statutory liability under the SFA in relation to the content of prospectuses does not apply, and investors should consider carefully whether the investment is suitable for them.


This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accept responsibility for its contents. This publication, and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act.

Morgan Stanley Investment Management is the asset management division of Morgan Stanley.

All information contained herein is proprietary and is protected under copyright law.

© 2017 Morgan Stanley. All rights reserved.

CRC 1946466 Exp. 11/30/2018

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.